1. Home
  2. BCRX vs ICFI Comparison

BCRX vs ICFI Comparison

Compare BCRX & ICFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • ICFI
  • Stock Information
  • Founded
  • BCRX 1986
  • ICFI 1969
  • Country
  • BCRX United States
  • ICFI United States
  • Employees
  • BCRX N/A
  • ICFI 9300
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • ICFI Professional Services
  • Sector
  • BCRX Health Care
  • ICFI Consumer Discretionary
  • Exchange
  • BCRX Nasdaq
  • ICFI Nasdaq
  • Market Cap
  • BCRX 1.9B
  • ICFI 1.8B
  • IPO Year
  • BCRX 1994
  • ICFI 2006
  • Fundamental
  • Price
  • BCRX $8.45
  • ICFI $98.50
  • Analyst Decision
  • BCRX Strong Buy
  • ICFI Buy
  • Analyst Count
  • BCRX 10
  • ICFI 4
  • Target Price
  • BCRX $16.70
  • ICFI $116.75
  • AVG Volume (30 Days)
  • BCRX 3.5M
  • ICFI 200.2K
  • Earning Date
  • BCRX 08-04-2025
  • ICFI 07-31-2025
  • Dividend Yield
  • BCRX N/A
  • ICFI 0.57%
  • EPS Growth
  • BCRX N/A
  • ICFI 10.29
  • EPS
  • BCRX N/A
  • ICFI 5.74
  • Revenue
  • BCRX $557,506,000.00
  • ICFI $1,977,095,000.00
  • Revenue This Year
  • BCRX $37.96
  • ICFI N/A
  • Revenue Next Year
  • BCRX $8.82
  • ICFI $1.54
  • P/E Ratio
  • BCRX N/A
  • ICFI $17.19
  • Revenue Growth
  • BCRX 45.85
  • ICFI N/A
  • 52 Week Low
  • BCRX $6.02
  • ICFI $75.91
  • 52 Week High
  • BCRX $11.31
  • ICFI $179.67
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 46.82
  • ICFI 73.36
  • Support Level
  • BCRX $8.08
  • ICFI $93.21
  • Resistance Level
  • BCRX $8.64
  • ICFI $99.98
  • Average True Range (ATR)
  • BCRX 0.33
  • ICFI 3.39
  • MACD
  • BCRX 0.06
  • ICFI 1.29
  • Stochastic Oscillator
  • BCRX 43.90
  • ICFI 91.79

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.

Share on Social Networks: